Articles

Alladapt Immunotherapeutics said the FDA Fast Track designation highlights the importance of developing a treatment for multiple food allergens.

Novel Multi-Food Allergy Immunotherapy Fast Tracked by FDA

Study aims to find ways industry gets involved in the most influential clinical trials, and how transparent these trials are.

Investigating Industry Involvement in Modern Clinical Trials

The CDMO’s GMP plant will dedicate 2,500 square feet to the storage of finished products.

SOHM Introduces New California Manufacturing Facility

IQVIA report explores why these shortages are increasing, and how they can be mitigated.

An Examination of US Drug Shortages’ Impact on the Supply Chain

Medication focuses on the acute treatment of migraines.

Phase 3 Study for AbbVie’s Ubrelvy Reports Promising Results

Study emphasizes role in bridging research and development and commercial/marketing functions.

The Importance of the Medical Affairs Function in Pharmaceutical Companies

IATA numbers point to continuing recovery.

September Sees a Boost in Air Cargo Demand

Purchase grows the company’s CRYOPDP domestic footprint while strengthening working relationship between both parties.

Cryoport Acquires Bluebird Express

The FDA also approved a companion diagnostic test to detect the PIK3CA, AKT1, and PTEN alterations as part of the approval for AstraZeneca’s capivasertib (Truqap) plus fulvestrant (Faslodex) for HR-positive, HER2-negative locally advanced or metastatic breast cancer.

Truqap Combination Approved by FDA for HR-Positive, HER2-Negative Locally Advanced, Metastatic Breast Cancer

Enzalutamide (Xtandi) gets FDA approval to treat nonmetastatic castration-sensitive prostate cancer with biochemical recurrence at high risk for metastasis.

News